These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32179033)

  • 21. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
    Yatsushiro Y; Nishikawa T; Saito A; Nakazawa Y; Imadome KI; Nakagawa S; Kodama Y; Okamoto Y; Kanegane H; Kawano Y
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e44-e46. PubMed ID: 29324572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The cutting-edge of medicine; Epstein-Barr virus associated lymphoproliferative disorders: disease concept and treatment].
    Suzuki R
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):979-85. PubMed ID: 23772516
    [No Abstract]   [Full Text] [Related]  

  • 23. EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.
    Satou A; Banno S; Hanamura I; Takahashi E; Takahara T; Nobata H; Katsuno T; Takami A; Ito Y; Ueda R; Nakamura S; Tsuzuki T
    Pathol Int; 2019 Jan; 69(1):21-28. PubMed ID: 30615240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD; Preiksaitis JK;
    Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-Occurrence of EBV-Positive Mucocutaneous Ulcer (EBV-MCU) and CLL/SLL in the Head and Neck Region.
    Bott P; Oschlies I; Radeloff A; Loewenthal M
    Curr Oncol; 2022 Apr; 29(4):2749-2767. PubMed ID: 35448198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fulminant Epstein-Barr virus-driven CD8 positive T-cell lymphoproliferative disorder with chromosomal abnormality.
    Tanoshima R; Goto H; Kato H; Yokosuka T; Kajiwara R; Yokota S
    Pediatr Blood Cancer; 2011 Jul; 57(1):182. PubMed ID: 21445947
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
    Maldonado NI; Cabanillas F; Jaffe ES; Raffeld M; Lozada L
    J Clin Oncol; 2011 Aug; 29(22):e658-60. PubMed ID: 21646613
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic ulceration of the tongue.
    Briody A; Santosh N; Allen CM; Mallery SR; McNamara KK
    J Am Dent Assoc; 2016 Sep; 147(9):744-8. PubMed ID: 27426484
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.
    van Esser JW; Niesters HG; van der Holt B; Meijer E; Osterhaus AD; Gratama JW; Verdonck LF; Löwenberg B; Cornelissen JJ
    Blood; 2002 Jun; 99(12):4364-9. PubMed ID: 12036863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral Epstein-Barr virus-positive mucocutaneous ulcer: gingival presentation of a benign lymphoproliferative lesion.
    Li DTS; Lo AWI; Su YX
    Int J Oral Maxillofac Surg; 2020 Oct; 49(10):1351-1354. PubMed ID: 31982237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
    Daroontum T; Kohno K; Inaguma Y; Okamoto A; Okamoto M; Kimura Y; Nagahama M; Sakakibara A; Satou A; Nakamura S
    Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-positive mucocutaneous ulcer in a patient with polycythemia vera treated with oral hydroxyurea.
    Hamada T; Kawata M; Maeda Y; Yoshino T; Miyake T; Morizane S; Hirai Y; Iwatsuki K
    J Dermatol; 2018 Apr; 45(4):e82-e83. PubMed ID: 29139148
    [No Abstract]   [Full Text] [Related]  

  • 33. An aggressive case of EBV-positive mucocutaneous ulcer in the female genital area; successful response to rituximab.
    Rodríguez-Lago L; Peñate Y; Marrero-Quintana MT; Andújar-Sánchez M; Rodríguez-López J
    Dermatol Ther; 2022 Jul; 35(7):e15527. PubMed ID: 35441767
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
    Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis on anti-CD20 antibody-treated Epstein-Barr virus-related posttransplantation lymphoproliferative disorder following ATG-based haploidentical T-replete hematopoietic stem cell transplantation.
    Luo XY; Mo XD; Xu LP; Zhang XH; Wang Y; Liu KY; Chang YJ; Zhao XY; Huang XJ
    Ann Hematol; 2020 Nov; 99(11):2649-2657. PubMed ID: 32206854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBV-positive Mucocutaneous Ulcer With Small Lymphocytic Infiltration Mimicking Nonspecific Ulceration.
    Fujimoto M; Kaku Y; Hirata M; Usui S; Yamada Y; Haga H
    Am J Surg Pathol; 2021 May; 45(5):694-700. PubMed ID: 33739792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr Virus Positive Mucocutaneous Ulcer: A Case Report.
    Gali V; Bleeker JS; Lynch D
    S D Med; 2018 Jun; 71(6):252-255. PubMed ID: 30005148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study.
    Wu M; Sun J; Zhang Y; Huang F; Zhou H; Fan Z; Xuan L; Yu G; Guo X; Dai M; Feng R; Liu Q
    Bone Marrow Transplant; 2016 Mar; 51(3):456-8. PubMed ID: 26595071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.